Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | bromodomain containing 2 | 0.0432 | 0.8944 | 0.8802 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0269 | 0.514 | 0.2658 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.017 | 0.2828 | 0.5 |
Schistosoma mansoni | RNA binding protein | 0.017 | 0.2828 | 0.1095 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0478 | 1 | 1 |
Brugia malayi | brahma associated protein 60 kDa | 0.0478 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.017 | 0.2828 | 0.5 |
Onchocerca volvulus | 0.0194 | 0.3381 | 0.0771 | |
Loa Loa (eye worm) | CBP-B | 0.01 | 0.1209 | 0.1209 |
Echinococcus granulosus | bromodomain containing 2 | 0.0432 | 0.8944 | 0.8824 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.017 | 0.2828 | 0.1095 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.017 | 0.2828 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.017 | 0.2828 | 0.2828 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0478 | 1 | 1 |
Echinococcus granulosus | ring and YY1 binding protein | 0.017 | 0.2828 | 0.2012 |
Loa Loa (eye worm) | hypothetical protein | 0.017 | 0.2828 | 0.2828 |
Leishmania major | hypothetical protein, conserved | 0.017 | 0.2828 | 0.5 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0432 | 0.8944 | 0.8405 |
Entamoeba histolytica | bromodomain-containing protein | 0.0194 | 0.3381 | 0.5 |
Brugia malayi | YY1-associated factor 2 | 0.017 | 0.2828 | 0.1095 |
Echinococcus granulosus | Nuclear pore complex protein Nup153 | 0.017 | 0.2828 | 0.2012 |
Loa Loa (eye worm) | brahma associated protein | 0.0478 | 1 | 1 |
Echinococcus multilocularis | zinc finger protein Ran binding | 0.017 | 0.2828 | 0.1861 |
Echinococcus granulosus | Zinc finger RanBP2 type | 0.017 | 0.2828 | 0.2012 |
Echinococcus multilocularis | Nuclear pore complex protein Nup153 | 0.017 | 0.2828 | 0.1861 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.017 | 0.2828 | 0.1095 |
Toxoplasma gondii | bromodomain-containing protein | 0.0194 | 0.3381 | 0.0771 |
Schistosoma mansoni | hypothetical protein | 0.0478 | 1 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.017 | 0.2828 | 0.1095 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0478 | 1 | 1 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.017 | 0.2828 | 0.5 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0478 | 1 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.017 | 0.2828 | 0.5 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.017 | 0.2828 | 0.1095 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0478 | 1 | 1 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0478 | 1 | 0.5 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0478 | 1 | 1 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0478 | 1 | 1 |
Schistosoma mansoni | fusion | 0.017 | 0.2828 | 0.1095 |
Giardia lamblia | Kinase, putative | 0.0194 | 0.3381 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.017 | 0.2828 | 0.2828 |
Schistosoma mansoni | hypothetical protein | 0.017 | 0.2828 | 0.1095 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.017 | 0.2828 | 0.5 |
Brugia malayi | Bromodomain containing protein | 0.0432 | 0.8944 | 0.8689 |
Schistosoma mansoni | brg-1 associated factor | 0.0478 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.017 | 0.2828 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0478 | 1 | 1 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0478 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0269 | 0.514 | 0.2658 |
Schistosoma mansoni | TRABID protein (C64 family) | 0.017 | 0.2828 | 0.1095 |
Leishmania major | hypothetical protein, conserved | 0.017 | 0.2828 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.017 | 0.2828 | 0.5 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0194 | 0.3381 | 0.3381 |
Loa Loa (eye worm) | hypothetical protein | 0.0432 | 0.8944 | 0.8944 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0478 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0478 | 1 | 1 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.017 | 0.2828 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0478 | 1 | 1 |
Schistosoma mansoni | bromodomain-containing protein 3 brd3 | 0.0432 | 0.8944 | 0.8689 |
Brugia malayi | hypothetical protein | 0.0163 | 0.2672 | 0.0901 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0478 | 1 | 1 |
Echinococcus multilocularis | ring and YY1 binding protein | 0.017 | 0.2828 | 0.1861 |
Trichomonas vaginalis | bromodomain containing protein, putative | 0.0269 | 0.514 | 0.2658 |
Echinococcus granulosus | zinc finger protein Ran binding | 0.017 | 0.2828 | 0.2012 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.017 | 0.2828 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.017 | 0.2828 | 0.2828 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.017 | 0.2828 | 0.5 |
Echinococcus multilocularis | Bromodomain containing protein | 0.0194 | 0.3381 | 0.2488 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0478 | 1 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0432 | 0.8944 | 0.8689 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0478 | 1 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.017 | 0.2828 | 0.5 |
Echinococcus granulosus | CREB binding protein | 0.0132 | 0.1946 | 0.1029 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0478 | 1 | 1 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0269 | 0.514 | 0.2658 |
Trypanosoma brucei | hypothetical protein, conserved | 0.017 | 0.2828 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.017 | 0.2828 | 0.5 |
Onchocerca volvulus | 0.0478 | 1 | 1 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0239 | 0.4431 | 0.1587 |
Loa Loa (eye worm) | hypothetical protein | 0.017 | 0.2828 | 0.2828 |
Entamoeba histolytica | bromodomain-containing protein | 0.0194 | 0.3381 | 0.5 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0269 | 0.514 | 0.2658 |
Plasmodium vivax | hypothetical protein, conserved | 0.0478 | 1 | 0.5 |
Entamoeba histolytica | bromodomain-containing protein | 0.0194 | 0.3381 | 0.5 |
Schistosoma mansoni | zinc finger protein | 0.017 | 0.2828 | 0.1095 |
Chlamydia trachomatis | SWIB complex protein | 0.0478 | 1 | 0.5 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.017 | 0.2828 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.017 | 0.2828 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.017 | 0.2828 | 0.5 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0432 | 0.8944 | 0.8405 |
Echinococcus multilocularis | Zinc finger, RanBP2 type | 0.017 | 0.2828 | 0.1861 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 32.9 | Lessening of memory impairment measured in mice; time of latency in seconds at an intravenous dose of 10 mg/kg. | ChEMBL. | 1977911 |
Activity (functional) | = 22 | Anticonflict activity measured in male wistar rats; number of shocks received in 5 min at an intrevenous dose of 10 mg/kg. | ChEMBL. | 1977911 |
Activity (functional) | = 32.9 | Lessening of memory impairment measured in mice; time of latency in seconds at an intravenous dose of 10 mg/kg. | ChEMBL. | 1977911 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.